Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Evaluation of VTE-PREDICT risk...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

Bibliographic Details
Main Authors: Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini
Format: Article
Language:English
Published: PAGEPress Publications 2024-04-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
VTE Predict score
Direct oral anticoagulants (DOACs)
Key words: direct oral anticoagulants, thrombophilia, thromboembolism, venous thrombosis
Online Access:https://www.mjhid.org/mjhid/article/view/5697
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.mjhid.org/mjhid/article/view/5697

Similar Items

  • SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP
    by: Alessandro Laganà, et al.
    Published: (2024-02-01)
  • Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
    by: Alexander T. Cohen, et al.
    Published: (2018-05-01)
  • Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
    by: Peter W. Ketch, et al.
    Published: (2024-12-01)
  • Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
    by: Maha Al-Ghafry, et al.
    Published: (2022-10-01)
  • Challenges in Management of VTE in Children With Cancer: Risk Factors and Treatment Options
    by: Nasrin Samji, et al.
    Published: (2022-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs